CS262200B1 - 1-tosylderivatives of ergoline and process for preparing thereof - Google Patents
1-tosylderivatives of ergoline and process for preparing thereof Download PDFInfo
- Publication number
- CS262200B1 CS262200B1 CS877732A CS773287A CS262200B1 CS 262200 B1 CS262200 B1 CS 262200B1 CS 877732 A CS877732 A CS 877732A CS 773287 A CS773287 A CS 773287A CS 262200 B1 CS262200 B1 CS 262200B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- ergoline
- configuration
- tosyl
- group
- tosylderivatives
- Prior art date
Links
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical class O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 5
- -1 cyanomethyl group Chemical group 0.000 claims abstract description 4
- 230000005595 deprotonation Effects 0.000 claims abstract description 4
- 238000010537 deprotonation reaction Methods 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 239000002243 precursor Substances 0.000 claims abstract description 3
- 239000000758 substrate Substances 0.000 claims description 4
- 239000003880 polar aprotic solvent Substances 0.000 claims description 3
- 239000012454 non-polar solvent Substances 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- JOAHPSVPXZTVEP-YXJHDRRASA-N Terguride Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NC(=O)N(CC)CC)=C3C2=CNC3=C1 JOAHPSVPXZTVEP-YXJHDRRASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- NESVMZOPWPCFAU-ZPRCMDFASA-N ergosine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C)C2)=C3C2=CNC3=C1 NESVMZOPWPCFAU-ZPRCMDFASA-N 0.000 description 1
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960004558 terguride Drugs 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1-tosylderiváty ergolinu obecného vzorce I, ve kterém R značí diethylamlnoureidovou skupinu s konfigurací 8a, tj. 8S, nebo kyanmethylovou skupinu s konfigurací 8/3, tj. 8R, a způsob jejich výroby deprotonací lH-prekursoru účinkem silné báze a reakcí vzniklé soli s tosylchloridem.1-tosyl derivatives of ergoline of the general formula Wherein R is diethylaminone a group having the configuration 8a, i.e. 8S, or cyanomethyl group with 8/3 configuration, ie 8R, and a process for their production by deprotonation of the 1H-precursor the effect of a strong base and the reactions formed salts with tosyl chloride.
Description
Vynález se týká 1-tosylderivátů ergolinu obecného vzorce IThe invention relates to ergosin 1-tosyl derivatives of the general formula I
ve kterémin which
R značí dlethylaminoureidovou skupinu [—NHCON(C2H5)2] s konfigurací 8a (tj. 8S) nebo kyanmethylovou skupinu (—CH2CN) s konfigurací &β (tj. 8R) a způsob jejich výroby.R denotes an 8a (i.e. 8S) -dlethylamino -reide group [—NHCON (C2H5) 2] ”or the < -β (i.e. 8R) -cyanomethyl group (—CH2CN) and a process for their preparation.
1-tosylderiváty ergolinu obecního vzorce I jsou cennými meziprodukty léčiv, vykazujících účinky na sekreci prolaktinu, na dopaminové receptory a účinky antipsychotické.The ergoline 1-tosylderivatives of formula I are valuable intermediates of drugs having effects on prolactin secretion, dopamine receptors and antipsychotic effects.
1-tosylderiváty ergolinu obecného vzorce I mají v molekule tři chirální centra, asymetrické uhlíky v polohách 5, 8 a 10, přičemž vodíkový atom na C(5) má polohu β (konfigurace 5R), skupina, vázaná na C(8) má ve shodě s obecným vzorcem (I) polohu a či β a vodíkový atom na C(10 j má polohu a (konfigurace 10R).The ergoline 1-tosylderivatives of formula (I) have three chiral centers in the molecule, asymmetric carbons at the 5, 8 and 10 positions, with the hydrogen atom on C (5) having the β position (5R configuration); in accordance with formula (I), the α or β position and the hydrogen atom on C (10 j has the α position (10R configuration).
Podle vynálezu se deriváty ergolinu obecného vzorce· I dají vyrábět tím způsobem, že se výchozí 1-H derivát ergolinu v nepolárním či polárním aprotickém rozpouštědle deprotonuje dostatečně silnou bází a na vzniklou sůl se působí tosylchloridem (p-toluensulfochloridemj.According to the invention, the ergoline derivatives of the formula (I) can be prepared by deprotonating the starting 1-H derivative of ergoline in a nonpolar or polar aprotic solvent with a sufficiently strong base and treating the resulting salt with tosyl chloride (p-toluenesulfochloride).
Reakce se výhodně provádí tak, že se výchozí ergolinový prekursor v polárním aprotickém rozpouštědle, jako je tetrahydrofuran, dioxam, 1,2-dimethoxyethan ěi dimethylsulfoxid uvede při teplotě —15 °C až +50 °C do styku s práškovým hydroxidem draselným, hydridem sodným, amidem sodným či dialkylamidem lithným (jako· je diisopropylamid llthnýj za míchání, s výhodou pod atmosférou inertního plynu, jako je dusík či argen, přičemž molární poměr deprotonaění činidlo/substrát činí 1 až 10 a po deprotonaci, trvající 10 minut až 4 hodiny se přidá přebytek tosylchloridu (přičemž molární poměr tosylchlorid/substrát činí 1,01 až 10). Po reakci, trvající 30 minut až 20 hodin a prováděné při teplotách 0 °C až při refluxu použitého rozpouštědla se reakční směs zpracuje postupy obvyklými v chemii derivátů ergolinu, například nalitím do vody, vytřepáním do rozpouštědla, nemísícího se s vodou, odpařením roztoku a chromatografií a/nebo krystalizací ze vhodného rozpouštědla.The reaction is preferably carried out by contacting the starting ergoline precursor in a polar aprotic solvent such as tetrahydrofuran, dioxam, 1,2-dimethoxyethane or dimethylsulfoxide at -15 ° C to + 50 ° C with powdered potassium hydroxide, sodium hydride sodium amide or lithium dialkylamide (such as lithium diisopropylamide with stirring, preferably under an inert gas atmosphere, such as nitrogen or argen), wherein the molar ratio of reagent / substrate deprotonation is 1-10 and after deprotonation lasting 10 minutes to 4 hours, add an excess of tosyl chloride (with a tosyl chloride / substrate molar ratio of 1.01 to 10.) After a reaction of 30 minutes to 20 hours and carried out at 0 ° C to the reflux temperature of the solvent used, the reaction mixture is worked up according to conventional methods of ergoline derivative chemistry. for example by pouring into water, shaking it into a water-immiscible solvent, evaporating r solution and chromatography and / or crystallization from a suitable solvent.
Sloučeniny obecného vzorce I jsou bezbarvé, dobře krystalizující látky, mírně bazického charakteru, poskytující adiční soli se silnými kyselinami.The compounds of formula (I) are colorless, well-crystallizing substances, of slightly basic character, providing addition salts with strong acids.
Způsob výroby 1-tosylderivátů ergolinu 0becného vzorce I je blíže objasněn v následujících příkladech, které však rozsah vynálezu nijak neomezují. Teploty tání jsou stanoveny na Koflerově bloku a jsou uvedeny ve °C.The following non-limiting examples illustrate the preparation of ergoline 1-tosyl derivatives of formula (I). Melting points are determined on a Kofler block and are reported in ° C.
Struktura látek byla potvrzena infračervenými, ultrafialovými a NMR spektry, složení elementární analýzou.Structure of compounds was confirmed by infrared, ultraviolet and NMR spectra, composition by elemental analysis.
Příklad 1Example 1
5/J,10a-8/2-kyanmethyl-6-methyl-l-tosylergolin5 ', 10a-8/2-cyanomethyl-6-methyl-1-tosylergoline
Do suspenze 795 mg (3 mmolů) 5β,10α-8β-kyanmethyl-6-methylergolinu v 90 ml abs. tetrahydrofuranu se za míchám pod dusíkem přidá 840 mg (T5 mmolů) práškového hydroxidu draselného a směs se míchá 30 minut. Pak se přidá 1 320 mg (6,9 mmolů) tosylchloridu, směs se 15 minut míchá a pak 7 hodin mírně refluxuje. Pak se po ochlazení nalije do 200 ml vody, okyselené 0,5 ml kys. octové a produkt se extrahuje 4 x 50 ml dichlormethanu. Spojené extrakty se vysuší bezv. síranem sodným a odpaří. Získaný odparek se krystalizuje z acetonu. Získá se tak 960 mg (76% teorie) přoduktu, t. t. 214 stupňů Celsia až 215,5 °C; specifická otáčivost [a]D2U = —33,13° (c — 0,2, chloroform). Příklad 2To a suspension of 795 mg (3 mmol) of 5β, 10α-8β-cyanomethyl-6-methylergoline in 90 ml abs. tetrahydrofuran was added with stirring, under nitrogen, 840 mg (T5 mmol) of powdered potassium hydroxide, and the mixture was stirred for 30 minutes. 1320 mg (6.9 mmol) of tosyl chloride are then added, the mixture is stirred for 15 minutes and then gently refluxed for 7 hours. After cooling, it is poured into 200 ml of water acidified with 0.5 ml of acetic acid and the product is extracted with 4 x 50 ml of dichloromethane. The combined extracts were dried. sodium sulfate and evaporated. The residue obtained is crystallized from acetone. This gives 960 mg (76% of theory) of the product, mp 214 ° C to 215.5 ° C; specific rotation [.alpha.] D @ 20 = -33.13 DEG (c = 0.2, chloroform). Example 2
Stejným postupem jako v příkladu 1, ale za použití 680 mg (2 mmoly) terguridu, 560 miligramů (10 mmolů) práškového hydroxidu draselného a 880 mg (4,6 mmolů) tosylchloridu v 15 ml abs. 1,2-dimethoxyethanu se po zpracování a chromatografickém čištění (chromatografie na silikagelu, eluce směsí chloroform — 1% ethanolu — 0,1% etriethylaminui) získá po krystalizací odparku sjednocených kvalitativně shodných frakcí z etheru 680 ml (69% teorie) N-(5/3,10a-6-:methyl-l-tosylergolin-8a-yl)-N‘,N‘-diethylmočoviny, t. t. 108 aC až 110 °C; specifická otáčivost [a]DZ0 — 0° (c = 0,2, pyridin).Using the same procedure as in Example 1, but using 680 mg (2 mmol) of terguride, 560 mg (10 mmol) of powdered potassium hydroxide and 880 mg (4.6 mmol) of tosyl chloride in 15 ml of abs. 1,2-dimethoxyethane is obtained after work-up and chromatographic purification (silica gel chromatography, eluting with chloroform-1% ethanol-0.1% ethylmethylamine) by crystallization of a residue of united qualitatively identical fractions from ether (680 ml, 69%). 5 / 3,10a-6-: methyl-1-tosylergolin-8a-yl) -N ', N'-diethylurea, mp 108 and C to 110 ° C; specific rotation [a] D Z0 - 0 ° (c = 0.2, pyridine).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS877732A CS262200B1 (en) | 1987-10-28 | 1987-10-28 | 1-tosylderivatives of ergoline and process for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS877732A CS262200B1 (en) | 1987-10-28 | 1987-10-28 | 1-tosylderivatives of ergoline and process for preparing thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CS773287A1 CS773287A1 (en) | 1988-07-15 |
CS262200B1 true CS262200B1 (en) | 1989-03-14 |
Family
ID=5426956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS877732A CS262200B1 (en) | 1987-10-28 | 1987-10-28 | 1-tosylderivatives of ergoline and process for preparing thereof |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS262200B1 (en) |
-
1987
- 1987-10-28 CS CS877732A patent/CS262200B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS773287A1 (en) | 1988-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU912045A3 (en) | Process for producing 6-substituted 8-methoxymethyl- or8-methylmercaprtomethylergolines or their salts | |
JP3262810B2 (en) | Chiral catalyst for ketone reduction and its preparation | |
JPS60358B2 (en) | Method for producing benzomorphan compounds | |
WO2006070349A2 (en) | Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride | |
NO752493L (en) | ||
JPS623154B2 (en) | ||
CS231214B1 (en) | Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea | |
CS262200B1 (en) | 1-tosylderivatives of ergoline and process for preparing thereof | |
JPH06501031A (en) | 2,14-disubstituted ergolines, their manufacture and use in medicines | |
US4968801A (en) | Process for the production ergoline derivatives | |
CS253742B2 (en) | Process for preparing beta-carbolines | |
SU908248A3 (en) | Process for preparing dibenzo-/a,d/-cyclooctene-6-12-imines or their pharmaceutically acceptable salts | |
JPH06509562A (en) | Gibberellin separation method | |
JPS607632B2 (en) | Method for producing thieno(3,2-C)pyridine and its derivatives | |
KR880000154B1 (en) | Method of preparing aminonitropyridine | |
AU2013363731B2 (en) | An improved process for making zilpaterol | |
JPS61286390A (en) | Method for producing 2-bromo-α-ergocriptine | |
US5099031A (en) | Process for the preparation of di- and trialkyl-4'-phthalimidomethylfurocoumarins | |
EP0551952B1 (en) | 17-Phenyl-substituted steroidal compounds active on the cardiovascular system | |
KR860001906B1 (en) | Method for preparing diamino pyridine | |
JP3495774B2 (en) | Method for producing 1-hydroxyindoles | |
US4321380A (en) | Alkyl cyanomethyl ergoline-I derivatives and salts thereof, and methods for their preparation | |
JPS61161278A (en) | Method for preparing 3-substituted indoles | |
JPS62142176A (en) | Production of ethyl apovincaminate ester | |
CS262581B1 (en) | 2-trifluoracetylderivatives of ergoline and process for preparing them |